Merck Withdraws Recarbrio Antibiotic From U.S. Market
Merck is halting U.S. production and distribution of Recarbrio, a specialized antibacterial combination drug designed to treat severe hospital-acquired infections and multidrug-resistant pathogens. The abrupt withdrawal…